Related Experiment Video
Updated: Jul 14, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
DA-Raf1, a competent intrinsic dominant-negative antagonist of the Ras-ERK pathway, is required for myogenic
Takashi Yokoyama1, Kazunori Takano, Akira Yoshida
1Department of Biology, Graduate School of Science, Chiba University, Chiba 263-8522, Japan.
Abstract:
Ras activates Raf, leading to the extracellular-regulated kinase (ERK)-mitogen-activated protein kinase pathway, which is involved in a variety of cellular, physiological, and pathological responses. Thus, regulators of this Ras-Raf interaction play crucial roles in these responses. In this study, we report a novel regulator of the Ras-Raf interaction named DA-Raf1. DA-Raf1 is a splicing isoform of A-Raf with a wider tissue distribution than A-Raf. It contains the Ras-binding domain but lacks the kinase domain, which is responsible for activation of the ERK pathway. As inferred from its structure, DA-Raf1 bound to activated Ras as well as M-Ras and interfered with the ERK pathway. The Ras-ERK pathway is essential for the negative regulation of myogenic differentiation induced by growth factors. DA-Raf1 served as a positive regulator of myogenic differentiation by inducing cell cycle arrest, the expression of myogenin and other muscle-specific proteins, and myotube formation. These results imply that DA-Raf1 is the first identified competent, intrinsic, dominant-negative antagonist of the Ras-ERK pathway.
Insights
Researchers discovered DA-Raf1, a novel protein that acts as a dominant-negative antagonist of the Ras-extracellular-regulated kinase (ERK) pathway. This finding offers new insights into regulating cellular processes like myogenic differentiation.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- The Ras-Raf-ERK pathway regulates crucial cellular functions.
- Understanding regulators of Ras-Raf interaction is vital for various physiological and pathological responses.
Purpose of the Study:
- To identify and characterize novel regulators of the Ras-Raf interaction.
- To investigate the role of DA-Raf1 in cellular signaling and differentiation.
Main Methods:
- Identification of DA-Raf1 as a splicing isoform of A-Raf.
- Analysis of DA-Raf1's structure and binding properties to Ras and M-Ras.
- Assessment of DA-Raf1's impact on the ERK pathway and myogenic differentiation.
Main Results:
- DA-Raf1 binds to activated Ras and M-Ras, inhibiting the ERK pathway.
- DA-Raf1 lacks kinase activity but possesses a Ras-binding domain.
- DA-Raf1 promotes myogenic differentiation by inducing cell cycle arrest and muscle-specific protein expression.
Conclusions:
- DA-Raf1 is a novel, intrinsic, dominant-negative antagonist of the Ras-ERK pathway.
- DA-Raf1 plays a positive regulatory role in myogenic differentiation.
- DA-Raf1 represents a new target for therapeutic interventions related to Ras-ERK pathway dysregulation.
Related Concept Videos
MAPK Signaling Cascades
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Negative Regulator Molecules
Cell Polarization by Rho Proteins
Regulation of Angiogenesis and Blood Supply

